MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

New Environmentally Efficient Contrast-Medium Packaging Developed

By MedImaging International staff writers
Posted on 04 Jan 2015
Print article
Medical imaging contrast agents are normally packaged in glass bottles which are energy-intensive to make, and are breakable. After their use glass contrast-agent bottles need to be separated from other medical waste, and must be autoclaved, and disposed of in landfill. In addition, shipping heavy glass bottles by air-freight is expensive and contributes carbon dioxide (CO2) emissions.

A Life-Cycle Analysis (LCA) in the International Journal of Life Cycle Assessment compared a single-dose (96 mL) +PLUSPAK polymer bottle to a traditional glass contrast media packaging bottle. The study looked at categories such as human health impacts, resources and ecosystems, ReCiPe LCA categories, and cumulative energy demand. The study conformed to the International Standards Organization ISO 14040/14044 standards and included a third-party critical review.

The results of the study show that the polymer packaging outperforms the glass bottle in every environmental category that was investigated. Reasons for the improved performance are due to lower material requirements, and lower manufacturing, distribution, end-of-life, and disposal impacts.

The +PLUSPAK polymer bottle was developed by GE Healthcare (Chalfont St Giles, Buckinghamshire, UK) as part of GE's ecoimagination program. All GE Healthcare Magnetic Resonance Imaging (MRI) and iodinated contrast media can be packaged the new polymer bottles.

Related Links:
GE Healthcare

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
New
Compact C-Arm
Arcovis DRF-C S21

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more